Metraipolis › archive › dc_20e7bb78f33d

Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemia — Europe PMC PMID:41878536

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41878536
DOI
10.3389/fonc.2026.1659341
License (as archived)
solo-consultazione
Archived
2026-11-05T00:28:26.749Z
SHA-256 of the archived text
2d3bd8d2e4661572af76605f09fc826986d48bb081abf88726fb94be69a68a95
Stable URL of this page
https://metraipolis.com/documento/dc_20e7bb78f33d

How to cite

Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemia — Europe PMC PMID:41878536 — Europe PMC (en), https://europepmc.org/article/MED/41878536 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_20e7bb78f33d (Metraipolis archive dc_20e7bb78f33d, sha256 2d3bd8d2e4661572af76605f09fc826986d48bb081abf88726fb94be69a68a95)
BibTeX
@misc{dc20e7bb78f33d,
  title = {Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemia — Europe PMC PMID:41878536},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41878536},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_20e7bb78f33d; sha256 2d3bd8d2e4661572af76605f09fc826986d48bb081abf88726fb94be69a68a95},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41878536. Agents can read the archived copy with the MCP tool read_document.